PRALUENT alirocumab (rch) 75mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 14 May 2024

PRALUENT alirocumab (rch) 150mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2024

GLENMARK MOMETASONE ALCOHOL FREE mometasone furoate 1 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 26 Apr 2024

APX-GABAPENTIN gabapentin 800 mg

Availability: Unavailable Deletion from market: 03 Jun 2024

TIH-METFORMIN metformin hydrochloride 850 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 17 May 2024

METALYSE tenecteplase (rch) 40mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 02 Sep 2024

NUCALA mepolizumab 100 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Aug 2024

CLINDAMYCIN BNM clindamycin (as hydrochloride) 150 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Aug 2024

INDOSYL MONO 2 perindopril erbumine 2mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025

INDOSYL MONO 4 perindopril erbumine 4mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025

INDOSYL MONO 8 perindopril erbumine 8mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025

INDOSYL COMBI 4/1.25 perindopril erbumine 4mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025